| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.988 | 0 | 0.995 | Angiotensin AT1 receptor antagonist | 0.995 0 CID_108185 0.066 0.004 CID_154699965 | CID_108185 | |
| 0.985 | 0.001 | 0.985 | Angiotensin AT2 receptor antagonist | 0.962 0.001 CID_108185 0.094 0.004 CID_154699965 | ||
| 0.984 | 0 | 0.992 | Angiotensin II receptor antagonist | 0.992 0 CID_108185 0.068 0.004 CID_154699965 | CID_108185 | |
| 0.98 | 0 | 0.993 | Angiotensin AT1B receptor antagonist | 0.993 0 CID_108185 | CID_108185 | |
| 0.954 | 0.001 | 0.954 | Angiotensin AT1A receptor antagonist | 0.937 0.001 CID_108185 0.047 0.004 CID_154699965 | ||
| 0.501 | 0.032 | 0.706 | 5 Hydroxytryptamine release inhibitor | 0.706 0.004 CID_108185 | CID_108185 | |
| 0.495 | 0.031 | 0.577 | Histamine release inhibitor | 0.577 0.012 CID_108185 | CID_108185 | |
| 0.46 | 0.004 | 0.571 | NADPH oxidase inhibitor | 0.571 0.004 CID_108185 | CID_108185 | |
| 0.477 | 0.037 | 0.477 | Calcium channel L-type activator | 0.355 0.113 CID_154699965 | ||
| 0.453 | 0.02 | 0.453 | Cardiotonic | 0.396 0.03 CID_108185 | ||
| 0.389 | 0.003 | 0.389 | Phosphodiesterase 7B inhibitor | 0.389 0.003 CID_108185 | ||
| 0.258 | 0.005 | 0.258 | Phosphodiesterase 3A inhibitor | 0.201 0.008 CID_108185 | ||
| 0.248 | 0.008 | 0.418 | Alcohol dehydrogenase inhibitor | 0.418 0.004 CID_108185 | CID_108185 | |
| 0.239 | 0.014 | 0.261 | Catenin beta inhibitor | 0.261 0.009 CID_108185 | CID_108185 | |
| 0.178 | 0.004 | 0.192 | Leukotriene D4 antagonist | 0.192 0.004 CID_108185 | CID_108185 | |
| 0.172 | 0.009 | 0.173 | Peroxisome proliferator-activated receptor gamma agonist | 0.173 0.009 CID_108185 | CID_108185 | |
| 0.148 | 0.005 | 0.162 | Glutamate (mGluR group II) agonist | 0.162 0.004 CID_108185 | CID_108185 | |
| 0.141 | 0.005 | 0.152 | Glutamate (mGluR2) agonist | 0.152 0.004 CID_108185 | CID_108185 | |
| 0.193 | 0.062 | 0.193 | Growth hormone agonist | 0.185 0.065 CID_108185 | ||
| 0.14 | 0.01 | 0.14 | Sphingosine 1-phosphate receptor 4 agonist | 0.096 0.027 CID_108185 | ||
| 0.122 | 0.005 | 0.122 | Sphingosine kinase 2 inhibitor | 0.063 0.028 CID_108185 | ||
| 0.107 | 0.005 | 0.186 | Nicotinic acid receptor 2 agonist | 0.186 0.004 CID_108185 | CID_108185 | |
| 0.158 | 0.059 | 0.203 | Hemostatic | 0.203 0.031 CID_108185 | CID_108185 | |
| 0.108 | 0.01 | 0.108 | Bombesin 3 receptor antagonist | 0.108 0.01 CID_108185 | ||
| 0.095 | 0.005 | 0.095 | Glutamate (mGluR group II) antagonist | 0.087 0.005 CID_108185 | ||
| 0.119 | 0.038 | 0.329 | Uric acid excretion stimulant | 0.329 0.005 CID_108185 | CID_108185 | |
| 0.106 | 0.033 | 0.153 | Glutamate receptor agonist | 0.153 0.017 CID_108185 | CID_108185 | |
| 0.077 | 0.005 | 0.077 | Glutamate (mGluR2) antagonist | 0.062 0.006 CID_108185 | ||
| 0.084 | 0.014 | 0.084 | Sphingosine kinase inhibitor | |||
| 0.092 | 0.026 | 0.096 | Glutamate (mGluR) agonist | 0.096 0.024 CID_108185 | CID_108185 | |
| 0.089 | 0.028 | 0.089 | Phosphodiesterase III inhibitor | 0.06 0.052 CID_108185 | ||
| 0.084 | 0.029 | 0.115 | Leukotriene antagonist | 0.115 0.016 CID_108185 | CID_108185 | |
| 0.076 | 0.023 | 0.076 | Phosphodiesterase 4C inhibitor | 0.073 0.025 CID_108185 | ||
| 0.069 | 0.015 | 0.078 | Leukotriene C antagonist | 0.078 0.009 CID_108185 | CID_108185 | |
| 0.055 | 0.01 | 0.089 | AMPA 2 receptor antagonist | 0.089 0.006 CID_108185 | CID_108185 | |
| 0.051 | 0.014 | 0.122 | Nicotinic acid receptor agonist | 0.122 0.004 CID_108185 | CID_108185 | |
| 0.065 | 0.032 | 0.066 | Phosphodiesterase 1A inhibitor | 0.066 0.03 CID_108185 | CID_108185 | |
| 0.046 | 0.014 | 0.054 | Leukotriene C4 antagonist | 0.054 0.008 CID_108185 | CID_108185 | |
| 0.053 | 0.023 | 0.053 | Phosphodiesterase 3B inhibitor | |||
| 0.079 | 0.048 | 0.084 | Phosphodiesterase 4D inhibitor | 0.084 0.045 CID_108185 | CID_108185 | |
| 0.066 | 0.036 | 0.066 | Phosphodiesterase 1C inhibitor | 0.058 0.053 CID_108185 | ||
| 0.047 | 0.019 | 0.047 | Growth hormone secretagogue receptor antagonist | |||
| 0.067 | 0.039 | 0.069 | Phosphodiesterase VII inhibitor | 0.069 0.036 CID_108185 | CID_108185 | |
| 0.073 | 0.047 | 0.073 | Phosphodiesterase VIII inhibitor | 0.067 0.061 CID_108185 | ||
| 0.058 | 0.033 | 0.115 | Prostaglandin antagonist | 0.115 0.014 CID_108185 | CID_108185 | |
| 0.053 | 0.034 | 0.054 | Carbonic anhydrase II stimulant | 0.054 0.031 CID_108185 | CID_108185 | |
| 0.023 | 0.014 | 0.029 | Bombesin agonist | 0.029 0.009 CID_108185 | CID_108185 | |
| 0.02 | 0.012 | 0.025 | Bombesin 3 receptor agonist | 0.025 0.008 CID_108185 | CID_108185 | |
| 0.034 | 0.031 | 0.037 | Carbonic anhydrase I stimulant | 0.037 0.027 CID_108185 | CID_108185 | |
| 0.037 | 0.034 | 0.042 | Glucagon-like peptide 1 receptor antagonist | 0.042 0.023 CID_108185 | CID_108185 | |
| 0.027 | 0.027 | 0.029 | CXC chemokine 3 receptor antagonist | 0.029 0.025 CID_108185 | CID_108185 | |
| 0.019 | 0.02 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 CID_108185 | CID_108185 | |
| 0.02 | 0.023 | 0.039 | Kainate receptor 4 antagonist | 0.039 0.01 CID_108185 | CID_108185 | |
| 0.038 | 0.044 | 0.064 | Glutamate (mGluR4) antagonist | 0.064 0.012 CID_108185 | CID_108185 | |
| 0.022 | 0.029 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.045 0.004 CID_108185 | CID_108185 | |
| 0.033 | 0.04 | 0.052 | Factor XIa inhibitor | 0.052 0.017 CID_108185 | CID_108185 | |
| 0.133 | 0.14 | 0.202 | I kappa B kinase epsilon inhibitor | 0.202 0.069 CID_108185 | CID_108185 | |
| 0.048 | 0.055 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.043 CID_108185 | CID_108185 | |
| 0.02 | 0.029 | 0.026 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 CID_108185 | CID_108185 | |
| 0.033 | 0.042 | 0.085 | AMPA 4 receptor antagonist | 0.085 0.006 CID_108185 | CID_108185 | |
| 0.02 | 0.033 | 0.042 | Endothelin receptor antagonist | 0.042 0.012 CID_108185 | CID_108185 | |
| 0.051 | 0.066 | 0.066 | Prostaglandin F2 alpha antagonist | 0.066 0.037 CID_108185 | CID_108185 | |
| 0.013 | 0.029 | 0.028 | Kainate receptor 5 antagonist | 0.028 0.01 CID_108185 | CID_108185 | |
| 0.043 | 0.06 | 0.052 | Autotaxin inhibitor | 0.052 0.037 CID_108185 | CID_108185 | |
| 0.011 | 0.029 | 0.017 | Kainate receptor 3 antagonist | 0.017 0.012 CID_108185 | CID_108185 | |
| 0.035 | 0.055 | 0.077 | AMPA receptor antagonist | 0.077 0.018 CID_108185 | CID_108185 | |
| 0.042 | 0.066 | 0.053 | Leukotriene B4 antagonist | 0.053 0.039 CID_108185 | CID_108185 | |
| 0.088 | 0.113 | 0.158 | Glutamate receptor antagonist | 0.158 0.046 CID_108185 | CID_108185 | |
| 0.012 | 0.039 | 0.022 | Endothelin A receptor antagonist | 0.022 0.014 CID_108185 | CID_108185 | |
| 0.029 | 0.059 | 0.049 | Oleamide hydrolase inhibitor | 0.049 0.028 CID_108185 | CID_108185 | |
| 0.034 | 0.068 | 0.054 | Glutamate (mGluR group III) antagonist | 0.054 0.017 CID_108185 | CID_108185 | |
| 0.024 | 0.06 | 0.089 | Urate transporter 1 inhibitor | 0.089 0.006 CID_108185 | CID_108185 | |
| 0.014 | 0.05 | 0.035 | AMPA 3 receptor antagonist | 0.035 0.017 CID_108185 | CID_108185 | |
| 0.028 | 0.066 | 0.086 | NMDA receptor subunit 3B antagonist | 0.086 0.013 CID_108185 | CID_108185 | |
| 0.061 | 0.109 | 0.088 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.088 0.051 CID_108185 | CID_108185 | |
| 0.071 | 0.123 | 0.085 | Xanthine oxidase inhibitor | 0.085 0.081 CID_108185 | CID_108185 | |
| 0.005 | 0.063 | 0.039 | Kainate receptor 1 antagonist | 0.039 0.007 CID_108185 | CID_108185 | |
| 0.027 | 0.088 | 0.061 | Prostaglandin E2 antagonist | 0.061 0.028 CID_108185 | CID_108185 | |
| 0.022 | 0.085 | 0.056 | Adenosine deaminase inhibitor | 0.056 0.025 CID_154699965 | CID_154699965 | |
| 0.018 | 0.082 | 0.067 | NMDA receptor subunit 3A antagonist | 0.067 0.015 CID_108185 | CID_108185 | |
| 0.007 | 0.08 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 CID_108185 | CID_108185 | |
| 0.05 | 0.131 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.047 CID_108185 | CID_108185 | |
| 0.016 | 0.1 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | 0.031 0.03 CID_108185 | CID_108185 | |
| 0.057 | 0.174 | 0.159 | DNA polymerase I inhibitor | 0.159 0.045 CID_154699965 | CID_154699965 | |
| 0.02 | 0.139 | 0.036 | Nicotinic acid receptor 1 agonist | 0.036 0.035 CID_108185 | CID_108185 | |
| 0.01 | 0.136 | 0.051 | Kainate receptor antagonist | 0.051 0.02 CID_108185 | CID_108185 | |
| 0.008 | 0.147 | 0.035 | Kainate receptor 2 antagonist | 0.035 0.025 CID_108185 | CID_108185 | |
| 0.148 | 0.302 | 0.229 | Interleukin 2 agonist | 0.229 0.144 CID_154699965 | CID_154699965 | |
| 0.005 | 0.245 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.014 CID_154699965 | CID_154699965 | |
| 0.005 | 0.29 | 0.204 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.204 0.002 CID_154699965 | CID_154699965 | |
| 0.015 | 0.331 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.031 CID_154699965 | CID_154699965 | |
| 0.008 | 0.534 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.066 0.009 CID_154699965 | CID_154699965 | |
| 0.049 | 0.62 | 0.159 | MAP kinase kinase 4 inhibitor | 0.159 0.047 CID_154699965 | CID_154699965 | |
| 0.005 | 0.631 | 0.071 | Neuraminidase inhibitor | 0.071 0.033 CID_154699965 | CID_154699965 | |
| 0.005 | 0.726 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.044 CID_154699965 | CID_154699965 | |
| 0.008 | 0.763 | 0.1 | Protein kinase C mu inhibitor | 0.1 0.057 CID_154699965 | CID_154699965 | |
| 0.06 | 0.818 | 0.207 | Peptidyltransferase inhibitor | 0.207 0.091 CID_154699965 | CID_154699965 | |
| 0.005 | 0.944 | 0.157 | Tumour necrosis factor alpha release inhibitor | 0.157 0.15 CID_154699965 | CID_154699965 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |